Structure, Function, and Amyloidogenesis of Fungal Prions: Filament Polymorphism and Prion Variants

Ulrich Baxa, Todd Cassese, Andrey V. Kajava, Alasdair C. Steven

Research output: Chapter in Book/Report/Conference proceedingChapter

45 Citations (Scopus)

Abstract

Infectious proteins (prions) became an important medical issue when they were identified as agents of the transmissible spongiform encephalopathies. More recently, prions have been found in fungi and their investigation has been facilitated by greater experimental tractability. In each case, the normal form of the prion protein may be converted into the infectious form (the prion itself) in an autocatalytic process; conversion may either occur spontaneously or by transmission from an already infected cell. Four fungal prion proteins have been studied in some depth-Ure2p, Sup35p, and Rnq1p of Saccharomyces cerevisiae and HET-s of Podospora anserina. Each has a "prion domain" that governs infectivity and a "functional domain" that contributes the protein's activity in a wild-type cell, if it has one. This activity is repressed in prion-infected cells for loss-of-activity prions, [URE3] (the prion of Ure2p) and [PSI] (the prion of Sup35p). For gain-of-activity prions, [PIN] (the prion of Rnq1p) and [Het-s] (the prion of HET-s), the prion domain is also involved in generating a new activity in infected cells. In prion conversion, prion domains polymerize into an amyloid filament, switching from a "natively unfolded" conformation into an amyloid conformation (stable, protease-resistant, rich in cross-β structure). For Ure2p and probably also Sup35p, the functional domain retains its globular fold but is inactivated by a steric mechanism. We review the evidence on which this scenario is based with emphasis on filament structure, summarizing current experimental constraints and appraising proposed models. We conclude that the parallel superpleated β-structure and a specific β-helical formulation are valid candidates while other proposals are excluded. In both the Ure2p and Sup35p systems, prion domain amyloid filaments exhibit polymorphic variation. However, once a certain structure is nucleated, it is maintained throughout that filament. Electron microscopy of several Ure2p-related constructs indicates that the basis for polymorphism lies mainly if not entirely in the prion domain. Filament polymorphism appears to underlie the phenomenon of prion "variants" which differ in the severity of their phenotype, that is, for Ure2p and Sup35p, the stringency with which their activity is switched off. We discuss a possible structural basis for this phenomenon.

Original languageEnglish (US)
Title of host publicationFibrous Proteins
Subtitle of host publicationAmyloids, Prions and Beta Proteins
EditorsAndrey Kajava, John Squire, David Parry
Pages125-180
Number of pages56
DOIs
StatePublished - Dec 27 2006
Externally publishedYes

Publication series

NameAdvances in Protein Chemistry
Volume73
ISSN (Print)0065-3233

Fingerprint

Prions
Polymorphism
Amyloid
Conformations
Podospora
Prion Diseases
Fungal Proteins
Fungi
Yeast
Electron microscopy

ASJC Scopus subject areas

  • Biochemistry

Cite this

Baxa, U., Cassese, T., Kajava, A. V., & Steven, A. C. (2006). Structure, Function, and Amyloidogenesis of Fungal Prions: Filament Polymorphism and Prion Variants. In A. Kajava, J. Squire, & D. Parry (Eds.), Fibrous Proteins: Amyloids, Prions and Beta Proteins (pp. 125-180). (Advances in Protein Chemistry; Vol. 73). https://doi.org/10.1016/S0065-3233(06)73005-4

Structure, Function, and Amyloidogenesis of Fungal Prions : Filament Polymorphism and Prion Variants. / Baxa, Ulrich; Cassese, Todd; Kajava, Andrey V.; Steven, Alasdair C.

Fibrous Proteins: Amyloids, Prions and Beta Proteins. ed. / Andrey Kajava; John Squire; David Parry. 2006. p. 125-180 (Advances in Protein Chemistry; Vol. 73).

Research output: Chapter in Book/Report/Conference proceedingChapter

Baxa, U, Cassese, T, Kajava, AV & Steven, AC 2006, Structure, Function, and Amyloidogenesis of Fungal Prions: Filament Polymorphism and Prion Variants. in A Kajava, J Squire & D Parry (eds), Fibrous Proteins: Amyloids, Prions and Beta Proteins. Advances in Protein Chemistry, vol. 73, pp. 125-180. https://doi.org/10.1016/S0065-3233(06)73005-4
Baxa U, Cassese T, Kajava AV, Steven AC. Structure, Function, and Amyloidogenesis of Fungal Prions: Filament Polymorphism and Prion Variants. In Kajava A, Squire J, Parry D, editors, Fibrous Proteins: Amyloids, Prions and Beta Proteins. 2006. p. 125-180. (Advances in Protein Chemistry). https://doi.org/10.1016/S0065-3233(06)73005-4
Baxa, Ulrich ; Cassese, Todd ; Kajava, Andrey V. ; Steven, Alasdair C. / Structure, Function, and Amyloidogenesis of Fungal Prions : Filament Polymorphism and Prion Variants. Fibrous Proteins: Amyloids, Prions and Beta Proteins. editor / Andrey Kajava ; John Squire ; David Parry. 2006. pp. 125-180 (Advances in Protein Chemistry).
@inbook{45c2faaf9f5d417ca0af2d007040ff6c,
title = "Structure, Function, and Amyloidogenesis of Fungal Prions: Filament Polymorphism and Prion Variants",
abstract = "Infectious proteins (prions) became an important medical issue when they were identified as agents of the transmissible spongiform encephalopathies. More recently, prions have been found in fungi and their investigation has been facilitated by greater experimental tractability. In each case, the normal form of the prion protein may be converted into the infectious form (the prion itself) in an autocatalytic process; conversion may either occur spontaneously or by transmission from an already infected cell. Four fungal prion proteins have been studied in some depth-Ure2p, Sup35p, and Rnq1p of Saccharomyces cerevisiae and HET-s of Podospora anserina. Each has a {"}prion domain{"} that governs infectivity and a {"}functional domain{"} that contributes the protein's activity in a wild-type cell, if it has one. This activity is repressed in prion-infected cells for loss-of-activity prions, [URE3] (the prion of Ure2p) and [PSI] (the prion of Sup35p). For gain-of-activity prions, [PIN] (the prion of Rnq1p) and [Het-s] (the prion of HET-s), the prion domain is also involved in generating a new activity in infected cells. In prion conversion, prion domains polymerize into an amyloid filament, switching from a {"}natively unfolded{"} conformation into an amyloid conformation (stable, protease-resistant, rich in cross-β structure). For Ure2p and probably also Sup35p, the functional domain retains its globular fold but is inactivated by a steric mechanism. We review the evidence on which this scenario is based with emphasis on filament structure, summarizing current experimental constraints and appraising proposed models. We conclude that the parallel superpleated β-structure and a specific β-helical formulation are valid candidates while other proposals are excluded. In both the Ure2p and Sup35p systems, prion domain amyloid filaments exhibit polymorphic variation. However, once a certain structure is nucleated, it is maintained throughout that filament. Electron microscopy of several Ure2p-related constructs indicates that the basis for polymorphism lies mainly if not entirely in the prion domain. Filament polymorphism appears to underlie the phenomenon of prion {"}variants{"} which differ in the severity of their phenotype, that is, for Ure2p and Sup35p, the stringency with which their activity is switched off. We discuss a possible structural basis for this phenomenon.",
author = "Ulrich Baxa and Todd Cassese and Kajava, {Andrey V.} and Steven, {Alasdair C.}",
year = "2006",
month = "12",
day = "27",
doi = "10.1016/S0065-3233(06)73005-4",
language = "English (US)",
isbn = "0120342731",
series = "Advances in Protein Chemistry",
pages = "125--180",
editor = "Andrey Kajava and John Squire and David Parry",
booktitle = "Fibrous Proteins",

}

TY - CHAP

T1 - Structure, Function, and Amyloidogenesis of Fungal Prions

T2 - Filament Polymorphism and Prion Variants

AU - Baxa, Ulrich

AU - Cassese, Todd

AU - Kajava, Andrey V.

AU - Steven, Alasdair C.

PY - 2006/12/27

Y1 - 2006/12/27

N2 - Infectious proteins (prions) became an important medical issue when they were identified as agents of the transmissible spongiform encephalopathies. More recently, prions have been found in fungi and their investigation has been facilitated by greater experimental tractability. In each case, the normal form of the prion protein may be converted into the infectious form (the prion itself) in an autocatalytic process; conversion may either occur spontaneously or by transmission from an already infected cell. Four fungal prion proteins have been studied in some depth-Ure2p, Sup35p, and Rnq1p of Saccharomyces cerevisiae and HET-s of Podospora anserina. Each has a "prion domain" that governs infectivity and a "functional domain" that contributes the protein's activity in a wild-type cell, if it has one. This activity is repressed in prion-infected cells for loss-of-activity prions, [URE3] (the prion of Ure2p) and [PSI] (the prion of Sup35p). For gain-of-activity prions, [PIN] (the prion of Rnq1p) and [Het-s] (the prion of HET-s), the prion domain is also involved in generating a new activity in infected cells. In prion conversion, prion domains polymerize into an amyloid filament, switching from a "natively unfolded" conformation into an amyloid conformation (stable, protease-resistant, rich in cross-β structure). For Ure2p and probably also Sup35p, the functional domain retains its globular fold but is inactivated by a steric mechanism. We review the evidence on which this scenario is based with emphasis on filament structure, summarizing current experimental constraints and appraising proposed models. We conclude that the parallel superpleated β-structure and a specific β-helical formulation are valid candidates while other proposals are excluded. In both the Ure2p and Sup35p systems, prion domain amyloid filaments exhibit polymorphic variation. However, once a certain structure is nucleated, it is maintained throughout that filament. Electron microscopy of several Ure2p-related constructs indicates that the basis for polymorphism lies mainly if not entirely in the prion domain. Filament polymorphism appears to underlie the phenomenon of prion "variants" which differ in the severity of their phenotype, that is, for Ure2p and Sup35p, the stringency with which their activity is switched off. We discuss a possible structural basis for this phenomenon.

AB - Infectious proteins (prions) became an important medical issue when they were identified as agents of the transmissible spongiform encephalopathies. More recently, prions have been found in fungi and their investigation has been facilitated by greater experimental tractability. In each case, the normal form of the prion protein may be converted into the infectious form (the prion itself) in an autocatalytic process; conversion may either occur spontaneously or by transmission from an already infected cell. Four fungal prion proteins have been studied in some depth-Ure2p, Sup35p, and Rnq1p of Saccharomyces cerevisiae and HET-s of Podospora anserina. Each has a "prion domain" that governs infectivity and a "functional domain" that contributes the protein's activity in a wild-type cell, if it has one. This activity is repressed in prion-infected cells for loss-of-activity prions, [URE3] (the prion of Ure2p) and [PSI] (the prion of Sup35p). For gain-of-activity prions, [PIN] (the prion of Rnq1p) and [Het-s] (the prion of HET-s), the prion domain is also involved in generating a new activity in infected cells. In prion conversion, prion domains polymerize into an amyloid filament, switching from a "natively unfolded" conformation into an amyloid conformation (stable, protease-resistant, rich in cross-β structure). For Ure2p and probably also Sup35p, the functional domain retains its globular fold but is inactivated by a steric mechanism. We review the evidence on which this scenario is based with emphasis on filament structure, summarizing current experimental constraints and appraising proposed models. We conclude that the parallel superpleated β-structure and a specific β-helical formulation are valid candidates while other proposals are excluded. In both the Ure2p and Sup35p systems, prion domain amyloid filaments exhibit polymorphic variation. However, once a certain structure is nucleated, it is maintained throughout that filament. Electron microscopy of several Ure2p-related constructs indicates that the basis for polymorphism lies mainly if not entirely in the prion domain. Filament polymorphism appears to underlie the phenomenon of prion "variants" which differ in the severity of their phenotype, that is, for Ure2p and Sup35p, the stringency with which their activity is switched off. We discuss a possible structural basis for this phenomenon.

UR - http://www.scopus.com/inward/record.url?scp=33845641044&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845641044&partnerID=8YFLogxK

U2 - 10.1016/S0065-3233(06)73005-4

DO - 10.1016/S0065-3233(06)73005-4

M3 - Chapter

C2 - 17190613

AN - SCOPUS:33845641044

SN - 0120342731

SN - 9780120342730

T3 - Advances in Protein Chemistry

SP - 125

EP - 180

BT - Fibrous Proteins

A2 - Kajava, Andrey

A2 - Squire, John

A2 - Parry, David

ER -